Focus: Resolute Science is a newly founded (2024) San Diego-based biotech specializing in macrophage-targeted conjugates, an emerging modality at the intersection of immunology and targeted drug delivery. The company is pre-revenue with no disclosed pipeline programs or active clinical trials.
Profile data last refreshed 4h ago · AI intelligence enriched 1mo ago
Growing — net +14 jobs in 30d
15 jobs added vs 1 removed. Steady team buildout.
Resolute Science is a speculative early-stage bet suitable only for risk-tolerant scientists or entrepreneurs seeking founder-level involvement; insufficient public data exists to assess career viability for most professionals.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Resolute Science
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Resolute Science's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles